Protein Engineering

Regenerative Medicine

Regenerative medicine is a division of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to reinstate or establish normal function. The latest developments in the regenerative medicine research involves advances in cell and gene therapy and stem cell research, molecular therapy, dental & craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are proficient of restoring the functionality of cells and tissues. The global regenerative medicine industry market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during prediction period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is expected to grow at a CAGR of 18.9% during the forecast period. As per the market analysis the research in this felid is highly concentrated in Europe which is interim as a platform to conduct central European conference on regenerative medicine.